89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
89bio (NASDAQ:ETNB – Free Report) had its target price raised by stock analysts at BTIG Research from $30.00 to $37.00 in a research note issued to investors on Sunday, The Fly reports. BTIG Research’s price target points to a potential upside of 95.25% from the stock’s current price. Other analysts also recently issued research reports […]
– Published data showed consistent and significant reductions in triglycerides, atherogenic lipoproteins and liver fat, and pegozafermin’s favorable safety.